JUNG LI: Open Payments
NPI 1720501240 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 8 payments from 5 companies in 2025. Trend: 2023 $277 · 2024 $292 · 2025 $991
Travel & lodging: $555Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $555 |
| ABBVIE INC. | 2 | $145 |
| Gilead Sciences, Inc. | 3 | $144 |
| Aimmune Therapeutics, Inc. | 1 | $124 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
Products named: TREMFYA, LINZESS, ZENPEP, Vemlidy, IQIRVO, SKYRIZI.
Industry payments across CA — which companies pay providers there.
